Who are the patients, and where are they? DAAP's AI drives omnichannel, next-best-action marketing through predictive targeting – drawing on de-identified patient, EHR, NPI, and engagement data to find and reach high-priority audiences during key windows in the care journey.

Only DAAP automatically segments audiences based on current and upcoming brand eligibility, so marketing dollars are directed towards patients and physicians when it is relevant, actionable, and timely to their needs—increasing engagement compared to reactive targeting.

Our omnichannel network encompasses 300+ EHRs and ePrescribing platforms, plus social and programmatic media, directing placement based on prior engagement and providing access to over 2 million HCPs and their patients—including those in underserved areas or populations.

DAAP combines multiple patented and patent-pending technologies into a single, integrated platform, including our predictive AI engine, privacy-safe Micro-Neighborhood® Targeting, and deterministic identity resolution.

Transparent reporting includes impressions by NPI, engagement by channel, and third-party script and patient impact analyses, so you can quantify and understand the commercial impact of your brand marketing programs.

DAAP unlocks the ability to synchronize provider and consumer marketing through a shared, brand-eligible audience that optimized for prescribing opportunities, with over 90% accuracy in timing brand communications to coincide.